Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000035647Phase 4Not yet recruiting
Phase 4, randomised, open-label trial of ropivacaine in postoperative pain and Shoulder disorder (3 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: systolic blood pressure, diastolic blood pressure and 3 more. Planned start Sep 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000035647.